Skip to main content
Elizabeth Jaffee, MD, Oncology, Baltimore, MD

ElizabethMarionJaffeeMD

Oncology Baltimore, MD

Gastrointestinal Cancer

Professor of Oncology and Professor of Pathology, Johns Hopkins University School of Medicine; The Dana and Albert "Cubby" Broccoli Professor of Oncology; Co-Director, Skip Viragh Center for Pancreas Cancer; Co-Director, Gastrointestinal Cancers Program; Co-Director of the Cancer Immunology Program and the Immunology and Hematopoiesis Division

Dr. Jaffee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jaffee's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-8964

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
  • UPMC Medical Education
    UPMC Medical EducationInternship, Internal Medicine, 1985 - 1986
  • New York Medical College
    New York Medical CollegeClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2026
  • PA State Medical License
    PA State Medical License 1986 - 1990
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic  
    Mark Yarchoan, Elizabeth Jaffee, Annals of Oncology

Press Mentions

  • Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
    Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 15th, 2024
  • Drug Combination Boosts Immune Response in Resistant Pancreatic Cancers
    Drug Combination Boosts Immune Response in Resistant Pancreatic CancersNovember 15th, 2024
  • Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
    Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 14th, 2024
  • Join now to see all